Tag: research

Researchers at the Centenary Institute have identified a potential breakthrough in the treatment of hepatocellular carcinoma (HCC), the most prevalent form of liver cancer and the third leading cause of cancer-related deaths worldwide.

Researchers at the University of Queensland (UQ) have identified a novel drug target that could potentially overcome drug resistance in cancer patients, thereby preventing tumour regrowth. 

Researchers from the Massachusetts Institute of Technology (MIT) have introduced Style2Fab, a generative AI tool that allows users to easily add custom design elements to 3D models without affecting their functionality.

Treasurer and Minister for Trade and Investment Cameron Dick has welcomed the extension of a significant research collaboration between the University of Queensland and the University of Tokyo on the opening day of his trade mission to Japan and Europe. 

The human brain is naturally equipped to perform intricate calculations, akin to high-powered computers, through a process known as Bayesian inference, according to a study published in the journal Nature Communications.

RMIT University researchers have invented a nano-thin superbug-killing substance that could be used in wound dressings and implants to prevent or repair bacterial infections.

Researchers are one step closer towards converting plant material into biofuels with a newly discovered method of optimising plant enzymes through bioengineering. 

A recent analysis from CSIRO, Australia's national science agency, has estimated that an emerging capacity that employs 'non-animal models' to evaluate novel medical goods could produce over $1.5 billion in revenue and create over 5,000 employment by 2040.

A team of scientists at the University of Sydney have successfully demonstrated the potential of quantum technology in exploring new designs in material science, drugs, or solar energy harvesting by slowing down a process critical in chemical reactions by a factor of 100 billion times. 

Australian pharmaceutical firm Phebra and the University of Wollongong (UOW) have entered into a six-year collaboration agreement to carry out research and development (R&D) and trials of patented and targeted arsenic compounds for the treatment of acute myeloid leukemias and pancreatic cancer.